Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm

Keyphrases

• Cystic Fibrosis 100%
• Lung Microbiome 100%
• Antibiotic Susceptibility 100%
• Multispecies Biofilm 100%
• Antibiotics 66%
• Pseudomonas Aeruginosa (P. aeruginosa) 50%
• Microbial Diversity 50%
• Poor Health 16%
• Antibiotic Treatment 16%
• Health Outcomes 16%
• Airway 16%
• Biofilm 16%
• Lung 16%
• Cystic Fibrosis Lung Infection 16%
• Achromobacter Xylosoxidans 16%
• Fusobacterium nucleatum (F. nucleatum) 16%
• Ceftazidime 16%
• Colistin 16%
• Tobramycin 16%
• Microbial Species 16%
• Biofilm Model 16%
• Microbiome 16%
• Prevotella Melaninogenica 16%
• Veillonella Parvula 16%
• Rothia mucilaginosa 16%
• Species Evenness 16%
• Streptococcus Anginosus 16%
• Gemella Haemolysans 16%
• Microaerophilic 16%
• Microbial Community Diversity 16%
• Staphylococcus Aureus and Pseudomonas Aeruginosa 16%
• Antipseudomonal Antibiotics 16%

Immunology and Microbiology

• Biofilm 100%
• Antibiotic Sensitivity 100%
• Microbiome 100%
• Lung 100%
• Pseudomonas aeruginosa 57%
• Microbial Diversity 42%
• Antimicrobial Agent 28%
• Infectious Agent 14%
• Achromobacter Xylosoxidans 14%
• Fusobacterium nucleatum 14%
• Staphylococcus Aureus 14%
• Infectious Disease 14%
• Colistin 14%
• Prevotella melaninogenica 14%
• Veillonella parvula 14%
• Rothia mucilaginosa 14%
• Streptococcus anginosus 14%
• Gemella haemolysans 14%
• Airway 14%
• Infection 14%
• Susceptibility 14%